Alice Zwerling, PhD, MSc, BSc
Tel.: 613-562-5800 x8277
Alice Zwerling is an Assistant Professor in the School of Epidemiology and Public Health at the University of Ottawa. As an infectious disease epidemiologist with a special interest in tuberculosis (TB) and a focus on health economics, her main areas of expertise and interest involve cost-effectiveness analyses to guide thoughtful implementation of new tools and treatment regimens for TB both globally and at home in Canada. Dr. Zwerling received her PhD in Epidemiology from McGill University, and specialized in health economics during a postdoctoral fellowship at the Johns Hopkins Bloomberg School of Public Health. For more than a decade Dr. Zwerling has worked with partners in India, Malawi, Cambodia, Myanmar, Bangladesh, South Africa, and many others to end TB in the developing world. Dr. Zwerling also works with the government of Nunavut to address key questions around TB elimination across the Canadian arctic and Canadian Inuit populations.
Infectious disease epidemiology, health economics, tuberculosis, global health, cost-effectiveness analysis, modelling, diagnostics, TB transmission, TB active case finding
1. Zwerling A, Dowdy D, von Delft A, Taylor H, Merritt MW. Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment. Int J Tuberc Lung Dis. 2017;21(11):69-74.
2. Zwerling A, Gomez GB, Pennington J, Cobelens F, Vassall A, Dowdy DW. A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens. Int J Tuberc Lung Dis. 2016;20(2):257-60.
3. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax. 2012;67(1):62-70.
4. Zwerling A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, et al. TB screening in Canadian health care workers using interferon-gamma release assays. PLoS One. 2012;7(8):e43014.